BioCentury | Oct 30, 2019
Emerging Company Profile

Disc Medicine: Seeking Iron Balance via Hepcidin

...for feedback on its hepcidin theories. He was founder and CEO of the now defunct Merganser Biotech Inc....
BioCentury | Jul 2, 2015
Company News

Management tracks

...Mass.) named Andrew Hack CFO. Hack was a portfolio manager at Millennium Management. Hematology play Merganser Biotech Inc....
BioCentury | Feb 23, 2015
Financial News

Merganser Biotech completes venture financing

Merganser Biotech Inc. , Newtown Square, Pa. Business: Hematology Date completed: 2015-02-19 Type: Venture financing Raised: $28 million Investors: Novartis Venture Funds; Frazier Healthcare; Sutter Hill Ventures; Osage University Partners; BioAdvance; Stateside Developments WIR Staff Hematology...
BioCentury | Feb 23, 2015
Financial News

Merganser Biotech completes venture financing

Merganser Biotech Inc. , Newtown Square, Pa. Business: Hematology Date completed: 2015-02-19 Type: Venture financing Raised: $28 million Investors: Novartis Venture Funds; Frazier Healthcare; Sutter Hill Ventures; Osage University Partners; BioAdvance; Stateside Developments WIR Staff Hematology...
BioCentury | Feb 23, 2015
Finance

Catching up in beta thalassemia

...Despite impressive data from more advanced therapies in beta thalassemia, investors in Merganser Biotech Inc. think there's still...
BioCentury | Feb 20, 2015
Financial News

Merganser raises $28M in series A

...Hematology play Merganser Biotech Inc. (Newtown Square, Pa.) raised $28 million in a series A round led by...
BioCentury | Jan 6, 2014
Company News

Merganser Biotech, Terapio, National Institutes of Health, University of North Carolina hematology, neurology, other news

...data to support 12 IND submissions to FDA, plus one trial application to Health Canada. Merganser Biotech...
BioCentury | Feb 25, 2013
Emerging Company Profile

Merganser: Hip to Hep

...Inc. (NASDAQ:ALNY), Cambridge, Mass. Celgene Corp. (NASDAQ:CELG), Summit, N.J. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Merganser Biotech Inc....
...Weill Cornell Medical College , New York, N.Y. Xenon Pharmaceuticals Inc. , Burnaby, B.C. Sidebars Merganser Biotech Inc....
BioCentury | Jul 2, 2012
Financial News

Merganser Biotech completes venture financing

Merganser Biotech Inc. , Newtown Square, Pa. Business: Hematology Date completed: 6/18/12 Type: Venture financing Raised: $50,000 Investor: BioAdvance WIR Staff...
BioCentury | Dec 19, 2011
Company News

Merganser Biotech, University of California deal

...to treat beta thalassemia and other diseases associated with iron overload. Details were not disclosed. Merganser Biotech Inc....
Items per page:
1 - 10 of 12
BioCentury | Oct 30, 2019
Emerging Company Profile

Disc Medicine: Seeking Iron Balance via Hepcidin

...for feedback on its hepcidin theories. He was founder and CEO of the now defunct Merganser Biotech Inc....
BioCentury | Jul 2, 2015
Company News

Management tracks

...Mass.) named Andrew Hack CFO. Hack was a portfolio manager at Millennium Management. Hematology play Merganser Biotech Inc....
BioCentury | Feb 23, 2015
Financial News

Merganser Biotech completes venture financing

Merganser Biotech Inc. , Newtown Square, Pa. Business: Hematology Date completed: 2015-02-19 Type: Venture financing Raised: $28 million Investors: Novartis Venture Funds; Frazier Healthcare; Sutter Hill Ventures; Osage University Partners; BioAdvance; Stateside Developments WIR Staff Hematology...
BioCentury | Feb 23, 2015
Financial News

Merganser Biotech completes venture financing

Merganser Biotech Inc. , Newtown Square, Pa. Business: Hematology Date completed: 2015-02-19 Type: Venture financing Raised: $28 million Investors: Novartis Venture Funds; Frazier Healthcare; Sutter Hill Ventures; Osage University Partners; BioAdvance; Stateside Developments WIR Staff Hematology...
BioCentury | Feb 23, 2015
Finance

Catching up in beta thalassemia

...Despite impressive data from more advanced therapies in beta thalassemia, investors in Merganser Biotech Inc. think there's still...
BioCentury | Feb 20, 2015
Financial News

Merganser raises $28M in series A

...Hematology play Merganser Biotech Inc. (Newtown Square, Pa.) raised $28 million in a series A round led by...
BioCentury | Jan 6, 2014
Company News

Merganser Biotech, Terapio, National Institutes of Health, University of North Carolina hematology, neurology, other news

...data to support 12 IND submissions to FDA, plus one trial application to Health Canada. Merganser Biotech...
BioCentury | Feb 25, 2013
Emerging Company Profile

Merganser: Hip to Hep

...Inc. (NASDAQ:ALNY), Cambridge, Mass. Celgene Corp. (NASDAQ:CELG), Summit, N.J. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Merganser Biotech Inc....
...Weill Cornell Medical College , New York, N.Y. Xenon Pharmaceuticals Inc. , Burnaby, B.C. Sidebars Merganser Biotech Inc....
BioCentury | Jul 2, 2012
Financial News

Merganser Biotech completes venture financing

Merganser Biotech Inc. , Newtown Square, Pa. Business: Hematology Date completed: 6/18/12 Type: Venture financing Raised: $50,000 Investor: BioAdvance WIR Staff...
BioCentury | Dec 19, 2011
Company News

Merganser Biotech, University of California deal

...to treat beta thalassemia and other diseases associated with iron overload. Details were not disclosed. Merganser Biotech Inc....
Items per page:
1 - 10 of 12